Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Asgn (ASGN) EBT (2016 - 2025)

Historic EBT for Asgn (ASGN) over the last 16 years, with Q3 2025 value amounting to $50.5 million.

  • Asgn's EBT fell 1971.38% to $50.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $182.4 million, marking a year-over-year decrease of 2630.3%. This contributed to the annual value of $240.1 million for FY2024, which is 1934.83% down from last year.
  • As of Q3 2025, Asgn's EBT stood at $50.5 million, which was down 1971.38% from $41.4 million recorded in Q2 2025.
  • Over the past 5 years, Asgn's EBT peaked at $100.0 million during Q2 2022, and registered a low of $31.2 million during Q1 2025.
  • In the last 5 years, Asgn's EBT had a median value of $68.8 million in 2023 and averaged $70.4 million.
  • As far as peak fluctuations go, Asgn's EBT skyrocketed by 5687.29% in 2022, and later tumbled by 4146.34% in 2025.
  • Quarter analysis of 5 years shows Asgn's EBT stood at $86.2 million in 2021, then fell by 11.83% to $76.0 million in 2022, then fell by 12.24% to $66.7 million in 2023, then dropped by 11.09% to $59.3 million in 2024, then fell by 14.84% to $50.5 million in 2025.
  • Its EBT was $50.5 million in Q3 2025, compared to $41.4 million in Q2 2025 and $31.2 million in Q1 2025.